141 related articles for article (PubMed ID: 23072735)
1. Identification of sites in apolipoprotein A-I susceptible to chymase and carboxypeptidase A digestion.
Usami Y; Kobayashi Y; Kameda T; Miyazaki A; Matsuda K; Sugano M; Kawasaki K; Kurihara Y; Kasama T; Tozuka M
Biosci Rep; 2012 Dec; 33(1):49-56. PubMed ID: 23072735
[TBL] [Abstract][Full Text] [Related]
2. Characterization of novel truncated apolipoprotein A-I in human high-density lipoprotein generated by sequential treatment with myeloperoxidase and chymase.
Lai SJ; Kameda T; Morita M; Yamagata Y; Nishizaka K; Horiuchi Y; Kobayashi Y; Usami Y; Liu JJ; Kasama T; Tozuka M; Ohkawa R
Biochimie; 2024 Mar; 218():34-45. PubMed ID: 37774825
[TBL] [Abstract][Full Text] [Related]
3. Detection of chymase-digested C-terminally truncated apolipoprotein A-I in normal human serum.
Usami Y; Matsuda K; Sugano M; Ishimine N; Kurihara Y; Sumida T; Yamauchi K; Tozuka M
J Immunol Methods; 2011 Jun; 369(1-2):51-8. PubMed ID: 21497162
[TBL] [Abstract][Full Text] [Related]
4. Chymase released from hypoxia-activated cardiac mast cells cleaves human apoA-I at Tyr
Kareinen I; Baumann M; Nguyen SD; Maaninka K; Anisimov A; Tozuka M; Jauhiainen M; Lee-Rueckert M; Kovanen PT
J Lipid Res; 2018 Jun; 59(6):945-957. PubMed ID: 29581158
[TBL] [Abstract][Full Text] [Related]
5. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
[TBL] [Abstract][Full Text] [Related]
6. Apolipoprotein composition and particle size affect HDL degradation by chymase: effect on cellular cholesterol efflux.
Lee M; Kovanen PT; Tedeschi G; Oungre E; Franceschini G; Calabresi L
J Lipid Res; 2003 Mar; 44(3):539-46. PubMed ID: 12562834
[TBL] [Abstract][Full Text] [Related]
7. Identification of domains in apoA-I susceptible to proteolysis by mast cell chymase. Implications for HDL function.
Lee M; Uboldi P; Giudice D; Catapano AL; Kovanen PT
J Lipid Res; 2000 Jun; 41(6):975-84. PubMed ID: 10828090
[TBL] [Abstract][Full Text] [Related]
8. Analysis of apolipoprotein A-I as a substrate for matrix metalloproteinase-14.
Park JH; Park SM; Park KH; Cho KH; Lee ST
Biochem Biophys Res Commun; 2011 May; 409(1):58-63. PubMed ID: 21549099
[TBL] [Abstract][Full Text] [Related]
9. Development of a new bioactivatable fluorescent probe for quantification of apolipoprotein A-I proteolytic degradation in vitro and in vivo.
Maafi F; Li B; Gebhard C; Brodeur MR; Nachar W; Villeneuve L; Lesage F; Rhainds D; Rhéaume E; Tardif JC
Atherosclerosis; 2017 Mar; 258():8-19. PubMed ID: 28167355
[TBL] [Abstract][Full Text] [Related]
10. Human apolipoprotein A-II determines plasma triglycerides by regulating lipoprotein lipase activity and high-density lipoprotein proteome.
Julve J; Escolà-Gil JC; Rotllan N; Fiévet C; Vallez E; de la Torre C; Ribas V; Sloan JH; Blanco-Vaca F
Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):232-8. PubMed ID: 19910634
[TBL] [Abstract][Full Text] [Related]
11. Mast cell chymase degrades apoE and apoA-II in apoA-I-knockout mouse plasma and reduces its ability to promote cellular cholesterol efflux.
Lee M; Calabresi L; Chiesa G; Franceschini G; Kovanen PT
Arterioscler Thromb Vasc Biol; 2002 Sep; 22(9):1475-81. PubMed ID: 12231569
[TBL] [Abstract][Full Text] [Related]
12. Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.
DiDonato JA; Aulak K; Huang Y; Wagner M; Gerstenecker G; Topbas C; Gogonea V; DiDonato AJ; Tang WHW; Mehl RA; Fox PL; Plow EF; Smith JD; Fisher EA; Hazen SL
J Biol Chem; 2014 Apr; 289(15):10276-10292. PubMed ID: 24558038
[TBL] [Abstract][Full Text] [Related]
13. Acrolein impairs ATP binding cassette transporter A1-dependent cholesterol export from cells through site-specific modification of apolipoprotein A-I.
Shao B; Fu X; McDonald TO; Green PS; Uchida K; O'Brien KD; Oram JF; Heinecke JW
J Biol Chem; 2005 Oct; 280(43):36386-96. PubMed ID: 16126721
[TBL] [Abstract][Full Text] [Related]
14. A proteolytic method for distinguishing between lipid-free and lipid-bound apolipoprotein A-I.
Safi W; Maiorano JN; Davidson WS
J Lipid Res; 2001 May; 42(5):864-72. PubMed ID: 11352994
[TBL] [Abstract][Full Text] [Related]
15. Low density lipoprotein degradation by secretory granules of rat mast cells. Sequential degradation of apolipoprotein B by granule chymase and carboxypeptidase A.
Kokkonen JO; Vartiainen M; Kovanen PT
J Biol Chem; 1986 Dec; 261(34):16067-72. PubMed ID: 3536921
[TBL] [Abstract][Full Text] [Related]
16. Matrix metalloproteinase 8 degrades apolipoprotein A-I and reduces its cholesterol efflux capacity.
Salminen A; Åström P; Metso J; Soliymani R; Salo T; Jauhiainen M; Pussinen PJ; Sorsa T
FASEB J; 2015 Apr; 29(4):1435-45. PubMed ID: 25550459
[TBL] [Abstract][Full Text] [Related]
17. Depletion of pre beta 1LpA1 and LpA4 particles by mast cell chymase reduces cholesterol efflux from macrophage foam cells induced by plasma.
Lee M; von Eckardstein A; Lindstedt L; Assmann G; Kovanen PT
Arterioscler Thromb Vasc Biol; 1999 Apr; 19(4):1066-74. PubMed ID: 10195937
[TBL] [Abstract][Full Text] [Related]
18. Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser228 severely impairs antiatherogenic capacity.
Dinnes DL; White MY; Kockx M; Traini M; Hsieh V; Kim MJ; Hou L; Jessup W; Rye KA; Thaysen-Andersen M; Cordwell SJ; Kritharides L
FASEB J; 2016 Dec; 30(12):4239-4255. PubMed ID: 27630170
[TBL] [Abstract][Full Text] [Related]
19. Depletion of pre-beta-high density lipoprotein by human chymase impairs ATP-binding cassette transporter A1- but not scavenger receptor class B type I-mediated lipid efflux to high density lipoprotein.
Favari E; Lee M; Calabresi L; Franceschini G; Zimetti F; Bernini F; Kovanen PT
J Biol Chem; 2004 Mar; 279(11):9930-6. PubMed ID: 14701812
[TBL] [Abstract][Full Text] [Related]
20. The carboxyl-terminal hydrophobic residues of apolipoprotein A-I affect its rate of phospholipid binding and its association with high density lipoprotein.
Laccotripe M; Makrides SC; Jonas A; Zannis VI
J Biol Chem; 1997 Jul; 272(28):17511-22. PubMed ID: 9211897
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
